NSE filing, NSE: SHAIVAL. Summary written from the filing by ALFA Finder's alert engine.
More from Shaival Reality Ltd
All →Shaival Reality Management Change
Shaival Reality Limited reported the resignation of Mrs. Rinkal M. Jasani as an Independent Director and the appointment of Mrs. Silva Sulabh Padshah as her replacement.
Shaival Reality H1 FY27 Results: Net Profit ₹2.9 Cr, Up 383.3% YoY
Shaival Reality Limited reported net profit of ₹2.9 Cr (+383.3% YoY) for H1 FY27.
- Key figure
- Net profit ₹2.9 Cr · +383.3% YoY
Shaival Reality H2 FY26 Results: Net Profit ₹5.2 Cr, Up 1200.0% YoY
Shaival Reality Limited approved audited standalone and consolidated financial results for the year ended March 31, 2026. The company reported standalone annual profit of ₹5.81 Crore. Additionally, the Board appointed Mr. Patel Sureshkumar Kantilal as Chief Financial Officer following the resignation of Mr. Bhavya Sandeep Kamdar.
- Key figure
- Net profit ₹5.2 Cr · +1200.0% YoY
Shaival Reality Other Announcement
Shaival Reality Limited submitted its System Driven Disclosure compliance certificate for FY 2025-26. The certificate, issued by Ronak Doshi & Associates, confirms the company maintains a functional, non-tamperable Structured Digital Database (SDD) as required by SEBI Insider Trading regulations.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.